WayBio Email Formats

Biotechnology Research • United States • 1-10 Employees

WayBio Email Formats

WayBio uses 2 email formats. The most common is {first initial} (e.g., j@waybio.us), used 66.7% of the time.

Format	Example	Percentage
{first initial}	j@waybio.us	66.7%
{first name}	john@waybio.us	33.3%

Key Contact at WayBio

Qiyuan Yang

Principal Scientist & Scientific Co-Founder

Company overview

Headquarters	United States
Website	waybio.us
NAICS	541714
Keywords	AAV, Crispr Gene Editing, Ai-Designed Sequences And Plasmids, Boston Biotech Services, Context-Aware Plasmid Design, Custom Plasmid Synthesis, Dna Plasmid Construction, Dna Plasmid Design, Dna Vector Optimization, Fast-Turnaround Plasmid Builds, Gene Cloning Services, Ip Protection For Biotech, Large Combo Mutant Library, Lenti Plasmid Build, Molecular Cloning Cro Services, Plasmid Cloning Services, Plasmid Inventory Management, Protein Engineering Support, Scientist-To-Scientist Collaboration, Secure Domestic Plasmid Provider, Mrna Vector Optimization
Employees	1-10
Socials

About WayBio

Boston-based Partner Research Organization delivering advanced plasmid DNA design, construction, and secure inventory management. We partner directly with scientists to simplify plasmid work, accelerate projects, and protect IP. Smart Design, Backed by Science ✅ Consultation and integrity guarantee ✅ Direct scientist-to-scientist collaboration ✅ Proprietary design tools Builds That Work the First Time ✅ Streamlined synthesis, assembly, verification, and delivery ✅ Elimination of redundant builds Local Access, Global Standards ✅ Boston-area same-day sample drop-off and rapid delivery ✅ Fully domestic operations for IP protection ✅ Reduced delays compared to overseas providers Results You Can Rely On ✅ Clients report up to 50% faster concept-to-construct timelines ✅ Defect-free plasmids guaranteed through full plasmid sequencing ✅ Trusted by innovators in cell and gene therapy, protein engineering, RNA therapy, and synthetic biology WayBio is committed to making plasmids easier to access, faster to build, and more reliable, helping science move forward.